arginine butyrate

DRUG4 trials

Sponsors

Susan P. Perrine, Boston University, Boston Medical Center, HemaQuest Pharmaceuticals Inc.

Conditions

Beta-ThalassemiaEBV LymphomasLeukemiaLympho-proliferative DiseasesLymphomaPrecancerous ConditionSickle Cell AnemiaSkin Ulcers

Phase 1

Ganciclovir Plus Arginine Butyrate in Treating Patients With Cancer or Lymphoproliferative Disorders Associated With the Epstein Barr Virus

CompletedNCT00006340

Boston Medical CenterLeukemia, Lymphoma, Precancerous Condition +1

Start: 1994-12-31End: 2000-07-31Updated: 2013-07-26

Phase 2

Phase II Randomized Trial:Arginine Butyrate Plus Standard Local Therapy in Patients With Refractory Sickle Cell Ulcers

CompletedNCT00004412

Susan P. PerrineSickle Cell Anemia, Skin Ulcers

Start: 1997-09-30End: 2005-02-28Updated: 2015-03-31

Phase II Study of Arginine Butyrate With or Without Epoetin Alfa in Patients With Thalassemia Intermedia

CompletedNCT00006136

Boston UniversityBeta-Thalassemia

Start: 1999-03-31Target: 15Updated: 2005-11-08

Study of Arginine Butyrate and Ganciclovir/Valganciclovir in EBV(+) Lymphoid Malignancies

TerminatedNCT00917826

HemaQuest Pharmaceuticals Inc.EBV Lymphomas, Lympho-proliferative Diseases

Start: 2008-09-30Updated: 2011-08-01